Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients1-Reference-Cited by-同舟云学术

Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients1

Published:2002-08 Issue:4 Volume:74 Page:488-496
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Ciancio Gaetano,Burke George W.,Garcia-Morales Rolando,Suzart Kiliana,Rosen Anne,Ricordi Camillo,Kenyon Norma S.,Mathew James M.,Tzakis Andreas G.,Esquenazi Violet,Miller Joshua

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference37 articles.

1. Mixed chimerism to induce tolerance for solid organ transplantation

2. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts

3. Mechanisms of Transplantation Tolerance

4. Transplantation tolerance

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differentiation of regulatory myeloid and T-cells from adult human hematopoietic stem cells after allogeneic stimulation;Frontiers in Immunology;2024-02-22

2. Hematopoietic cell-based and non-hematopoietic cell-based strategies for immune tolerance induction in living-donor renal transplantation: A systematic review;Transplantation Reviews;2023-12

3. Case report on prolonged kidney graft survival without immunosuppressive therapy after allogeneic hematopoietic stem cell transplantation;Russian Journal of Transplantology and Artificial Organs;2023-10-11

4. Case report on prolonged kidney graft survival without immunos uppressive therapy after allogeneic hematopoietic stem cell transplantation;VESTN TRANSPL ISKUSS;2023

5. A Prospective Controlled Trial to Evaluate Safety and Efficacy of in vitro Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001);Frontiers in Medicine;2021-01-27